Dna Next Generation Sequencing Market Scope And Analysis

  • Report Code : TIPRE00002934
  • Category : Biotechnology
  • Status : Published
  • No. of Pages : 246
Buy Now

DNA Next Generation Sequencing Market Scope and Analysis Report by 2025

Buy Now


DNA Next Generation Sequencing Market Report Scope

Report Attribute Details
Market size in 2017 US$ 4.9 Billion
Market Size by 2025 US$ 22.72 Billion
Global CAGR (2017 - 2025) 21.7%
Historical Data 2015-2016
Forecast period 2018-2025
Segments Covered By Product
  • Platforms
  • Services and Consumables
By Application
  • Diagnostics
  • Drug Discovery
  • Precision Medicine
  • & Other Applications
By End User
  • Academic & Research Institutes
  • Pharmaceutical & Biotechnology Companies
  • Hospitals Clinics
  • & Other End Users
Regions and Countries Covered North America
  • US
  • Canada
  • Mexico
Europe
  • UK
  • Germany
  • France
  • Russia
  • Italy
  • Rest of Europe
Asia-Pacific
  • China
  • India
  • Japan
  • Australia
  • Rest of Asia-Pacific
South and Central America
  • Brazil
  • Argentina
  • Rest of South and Central America
Middle East and Africa
  • South Africa
  • Saudi Arabia
  • UAE
  • Rest of Middle East and Africa
Market leaders and key company profiles
  • Illumina Inc
  • Thermo Fisher
  • Qiagen N V
  • Beijing Genomics Institute
  • PerkinElmer Inc
  • Hoffman La Roche Ltd
  • Agilent Technologies
  • Eurofins Scientific
  • Oxford Nanopore Technologies Ltd
  • Product launches and approvals are commonly adopted strategies by companies to expand their global footprints and product portfolios. Moreover, the market players focus on the partnership strategy to enlarge their clientele, which, in turn, permits them to maintain their brand name across the world. The market share is anticipated to flourish with the development of new innovative products by market players. Some of the market participants present in the concerned market are THERMO FISHER SCIENTIFIC INC.; Illumina, Inc; Qiagen N.V.; Beijing Genomics Institute; PerkinElmer, Inc.; F.Hoffman-La Roche Ltd.; Agilent Technologies; Eurofins Scientific; Oxford Nanopore Technologies Ltd; and Macrogen Inc.